IMPL
Impel Neuropharma Inc
Price:  
0.24 
USD
Volume:  
858,521.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMPL Stock Forecast & Price Target

IMPL Stock Price Forecast

The average stock forecast for Impel Neuropharma Inc (IMPL) in the next 12 months is 40.80 USD. This price target corresponds to an upside of 16,822.44%. The range of stock forecasts for IMPL is 40.40 - 42.00 USD. Based on the ratings of 0 analysts, the consensus recommendation for IMPL is HOLD.
Target Low Average Median High
Price (USD) 40.40 40.80 40.80 42.00
Upside 16,656.53% 16,822.44% 16,822.44% 17,320.16%

Recommendation Trends

The latest consensus rating for IMPL is "HOLD". This is the average recommendation of 0 analysts: strong sell, sell, hold, buy, strong buy. In the previous period, 0 analysts also majorly recommmended "HOLD" for IMPL.

IMPL Financial Stock Forecast

Revenue This Year
28.70M
126.88%
from 12.65M
Revenue Next Year
50.90M
77.35%
from 28.70M
EPS This Year
-1.63
-63.41%
from -4.45
EPS Next Year
-0.90
-44.94%
from -1.63